ERYTECH welcomes new US and European investors

Post author:admERY
Post published:February 13, 2014
Post category:Newsroom

ERYTECH was informed today that certain of its historical institutional investors have sold part of their holdings to new specialized life sciences investors in the United States and in Europe.

You Might Also Like

ERYTECH to report positive initial results on the use of GRASPA® in ALL patients allergic to E. Coli and Erwinia derived asparaginases at ASH

ERYTECH to Host on September 22, 2020 Second Quarter 2020 Conference Call and Business Update

ERYTECH reports positive Phase 2b data for eryaspase for the treatment of metastatic pancreatic cancer